drugset / Trial / NCT01927913
Treatment of Iron Overload Requiring Chelation Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this open-label study is to assess liver iron concentration using MRI imaging in subjects with beta-thalassemia when administered with either SPD602 or deferasirox for the treatment of chronic transfusional iron overload.
Timeline
- Start
- 2014-11-20
- Primary completion
- 2015-10-30
- Completion
- 2015-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Deferasirox | Unknown | — | — |
| Subject | SPD602 | Unknown | 32 mg/kg | — |
| Subject | SPD602 | Unknown | 50 mg/kg | — |
| Subject | SPD602 | Unknown | 75 mg/kg | — |